Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on Neurocrine Bio. (NBIX)

August 3, 2026 6:54 AM
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating and $215.00 price target on Neurocrine Bio. (NASDAQ: NBIX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments